Overview

Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma

Status:
Completed

Trial end date:
2015-09-01

Target enrollment:

Participant gender:

Summary

The goals of this protocol are to determine the effect of oxaliplatin, cytosine arabinoside, and dexamethasone with Rituxan (ROAD) as treatment for patients with relapsed CD20+ B-cell non-Hodgkins lymphoma (NHL).

Phase:

Phase 2

Details

Lead Sponsor:

Academic and Community Cancer Research United
Mayo Clinic

Collaborator:

Mayo Clinic

Treatments:

BB 1101
Cytarabine
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Oxaliplatin
Rituximab